Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Cough Syrup Market Outlook

The global cough syrup market size attained a value of about USD 6,222.00 million in 2023, driven by increasing cases of respiratory disorders, rising geriatric population, increased investments in R&D and innovations like new flavours for newborns, are aiding the market growth. The market is further expected to grow at a CAGR of 3.8% during the forecast period of 2024-2032 to reach nearly USD 8,703.75 million by 2032.

Global Cough Syrup Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The Asia Pacific and the Latin America Region to Propel the Market Growth of Cough Syrup

Due to easier availability of cough syrups at retail pharmacies, a rise in the geriatric population, and less stringent laws regarding the abuse of cough and cold medicines in the region, the Asia Pacific accounted for a significant market share in 2019, based on revenue, and is expected to maintain its significance during the forecast period as well.

However, because governments are investing in the development of healthcare infrastructure and as the number of instances of respiratory illnesses rises, LAMEA is predicted to have a substantial CAGR throughout the forecast period. Cough syrup industry growth is likely to be aided by the high market potential in unexplored emerging markets.

Cough Syrup: Market Segmentation

Cough syrups have been used since ancient times to provide temporary relief to people suffering from sneezing, coughing, and runny noses, which are typically caused by a cold, a high temperature, or allergies. Cough syrups are prescribed by doctors and can be used by both adults and children. Cough syrups contain anti-allergic and mucolytic medicines, which give speedier relief from cough-related difficulties. It often inhibits the heavy mucus layer, allowing the patient to breathe normally and comfortably.

Global Cough Syrup Market by Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Breakup by Product Type

  • Expectorants
  • Cough Suppressants
  • Combination Medications
  • Others

Market Breakup by Population Type

  • Paediatric
  • Adults

Market Breakup by Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Channel
  • Public Channel

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

The Increasing Demand for Smokeless Tobacco to Aid the Market Growth of Cough Syrup

The global demand for cough syrup is steadily rising, owing to a growth in the number of people suffering from chronic and acute respiratory disorders, such as asthma. In addition, the demand for cough syrup in the worldwide market is driven by the proportion of the geriatric population who are mostly suffering from chest-related issues. The simple availability of products in clinics is another element contributing to cough syrup's growing market share in the worldwide market. During the forecast period, the expanding research and development in the cough syrup industry are expected to create numerous growth chances in the worldwide market. In addition, cough syrup innovation in terms of flavour for newborns gives potential in the worldwide cough syrup industry. The growing public awareness also lays the groundwork for future global commercial potential.

Global Cough Syrup Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Key Players in the Global Cough Syrup Market

The report gives a detailed analysis of the following key players in the global cough syrup market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Acella Pharmaceuticals LLC
  • Bayer AG
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Pfizer Inc.
  • Prestige Consumer Healthcare Inc.
  • Reckitt Benckiser Group PLC
  • Sanofi
  • Sun Pharmaceutical Industries Limited
  • The Procter & Gamble Company

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product Type
  • Population Type
  • Distribution Channel
  • Region
Breakup by Product Type
  • Expectorants
  • Cough Suppressants
  • Combination Medications
  • Others
Breakup by Population Type
  • Paediatric
  • Adult
Breakup by Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Channel
  • Public Channel
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT analysis
  • Porter's Five Forces
  • Key Indicators for Demand
  • Key Indicators for Price
  • Industry Events, Initiatives, and Trends
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Acella Pharmaceuticals LLC
  • Bayer AG
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Pfizer Inc.
  • Prestige Consumer Healthcare Inc.
  • Reckitt Benckiser Group PLC
  • Sanofi
  • Sun Pharmaceutical Industries Limited
  • The Procter & Gamble Company
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us today for customized, data-driven solutions tailored to your unique requirements!

Key Questions Answered in the Report

In 2023, the global market for cough syrup attained a value of USD 6,222.00 million.

The market is anticipated to grow at a CAGR of 3.8% during the forecast period of 2024-2032 to reach a value of USD 8,703.75 million by 2032.

The major drivers of the industry, such as increasing cases of respiratory disorders, rising geriatric population, increased investments in R&D and innovations like new flavours for newborns, are aiding the market growth.

The key market trend guiding the growth of the industry includes growing government investment and healthcare infrastructure.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The significant product types in the market include expectorants, cough suppressants, and combination medications.

The different age groups in the market for cough syrup are paediatric and adult.

The leading distribution channels in the market are retail pharmacy, hospital pharmacy, and online pharmacy.

The major players in the industry are Sanofi, GlaxoSmithKline plc, Mankind Pharma Ltd., Novartis AG, and Reckitt Benckiser Group Plc, among others.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

Back to top

We’re here to help answer any questions about our products and services.

Contact us

Locations


United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124